Cramer Interviews Acorda Therapeutics CEO
On Tuesday, Acorda Therapeutics CEO Ron Cohen appeared on “Mad Money” to offer insight on his company’s multiple sclerosis drug "AMPYRA.”
To Cramer, the drug could be a huge driver for the stock . But he wanted to get the perspective of the company’s CEO, so he was happy to chat with Cohen. Watch the video to see the full interview.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? firstname.lastname@example.org
Questions, comments, suggestions for the Mad Money website? email@example.com